Portal de investigação
Management of Renin-Angiotensin-Aldosterone System Blockade in Patients Admitted in Hospital With Confirmed Coronavirus Disease (COVID-19) Infection: The McGill RAAS-COVID-19 Randomized Controlled Trial
Autores da FMUP
Participantes de fora da FMUP
- Sharma, A
- Elharram, M
- Ni, JY
- Afilalo, J
- Flannery, RNA
- Ezekowitz, J
- Cheng, MP
- Ambrosy, AP
- Zannad, F
- Brophy, J
- Giannetti, N
- Bessissow, A
- Kronfli, N
- Marelli, AJ
- Aziz, H
- AlQahtani, M
- Aflaki, M
- Craig, M
- Lopes, RD
Unidades de investigação
Abstract
Abstract no disponible
Filiações
Filiações não disponíveis
Proyectos asociados
Dapagliflozin, Spironolactone or Both for HFpEF (SOGALDI-PEF) - NCT05676684
Investigador Principal: João Pedro Melo Marques Pinho Ferreira
Ensaio Clínico Académico (SOGALDI-PEF) . AstraZeneca . 2022
Citar a publicação
Sharma,A,Elharram,M,Ni,JY,Afilalo,J,Flannery,R,Ezekowitz,J,Cheng,MP et al. Management of Renin-Angiotensin-Aldosterone System Blockade in Patients Admitted in Hospital With Confirmed Coronavirus Disease (COVID-19) Infection: The McGill RAAS-COVID-19 Randomized Controlled Trial. Annual Scientific Sessions of the American-Heart-Association / Resuscitation Science Symposium. 2021. Boston. TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA:Lippincott Williams and Wilkins Ltd. 2021.
